The market in diabetes

被引：31

作者：

Hauber, A

Gale, EAM

机构：

[1] Univ Bristol, Southmead Hosp, Sch Med, Unit Diabet & Metab, Bristol BS10 5NB, Avon, England

[2] Bear Stearns Int, London, England

来源：

DIABETOLOGIA | 2006年 / 49卷 / 02期

关键词：

D O I：

10.1007/s00125-005-0108-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：247 / 252

页数：6

共 13 条

[1] The metabolic syndrome - a new worldwide definition
Alberti, KGMM
Zimmet, P
Shaw, J
[J]. LANCET, 2005, 366 (9491) : 1059 - 1062
[2] Selling safety - Lessons from muraglitazar
Brophy, JM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20): : 2633 - 2635
[3] Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Despres, JP
Golay, A
Sjostrom, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) : 2121 - 2134
[4] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
Dormandy, JA
Charbonnel, B
Eckland, DJA
Erdmann, E
Massi-Benedetti, M
Kmoules, IK
Skene, AM
Tan, MH
Lefébvre, PJ
Murray, GD
Standl, E
Wilcox, RG
Wlhelmsen, L
Betteridge, J
Birkeland, K
Golay, A
Heine, RJ
Korányi, L
Laakso, M
Mokán, M
Norkus, A
Pirags, V
Podar, T
Scheen, A
Scherbaum, W
Schernthaner, G
Schmitz, O
Skrha, J
Smith, U
Taton, J
[J]. LANCET, 2005, 366 (9493) : 1279 - 1289
[5] FLEMING T, 2004, RED BOOK PHARM FUNDA
[6] Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute
Grundy, SM
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (11) : 2243 - 2244
[7] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Grundy, SM
Cleeman, JI
Daniels, SR
Donato, KA
Eckel, RH
Franklin, BA
Gordon, DJ
Krauss, RM
Savage, PJ
Smith, SC
Spertus, JA
Costa, F
[J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752
[8] HOLST JJ, 2006, IN PRESS DIABETOLOGI
[9] Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2
[10] Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512

← 1 2 →